N/A
N=3
SCED - Wisdom Enhancement for Post-Stroke Depression
Post-stroke Depression
Bottom Line
View on ClinicalTrials.gov: NCT06451965 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Visual Analogue Scale (VAS) - Mood — 3.53; 5.23 Scores on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Timeline Intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of East Anglia
- Primary completion
- Feb 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Analogue Scale (VAS) - Mood |
3.53; 5.23 | — |
| PRIMARY Visual Analogue Scale (VAS) - Identity |
2.55; 5.09 | — |
| PRIMARY Visual Analogue Scale (VAS) - Wisdom |
2.79; 5.56 | — |
| PRIMARY Visual Analogue Scale (VAS) - Self-esteem |
3; 4.92 | — |
| SECONDARY Patient Health Questionnaire (PHQ-9) |
13.66; 7.33 | — |
Summary
One-third of stroke survivors experience post-stroke depression, but there are currently no official guidelines for supporting them. Researchers aim to investigate whether the wisdom enhancement timeline technique can reduce depression in stroke survivors. The investigators also want to understand how this technique positively impacts mood, identity, self-esteem, and wisdom. The study will involve nine stroke survivors from the National Health Service (NHS) to gain insights into effective ways to support those with post-stroke depression.
Eligibility Criteria
Inclusion Criteria
- Had a stroke.
- Those who self-report as having difficulties with depression to a clinician.
- Have sufficient cognitive and communication abilities for informed consent and active engagement
Exclusion Criteria
- Under the age of 18. Because this is the age when they are treated as an adult by UK law.
- Severe cognitive impairments or mental health difficulties that would hinder task engagement or provide informed consent.
- Medical instability jeopardising consistent participation or well-being.
- Significant risk concerns regarding safety to themselves or others.
- Substance use/dependency impacting adherence.
- Prescribed psychotropic medication less than 3 months ago.
- Currently involved in research.
Data sourced from ClinicalTrials.gov (NCT06451965). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.